Cannabis products: medical use
- PMID: 36921194
- PMCID: PMC10004278
- DOI: 10.1590/1806-9282.2023D693
Cannabis products: medical use
Erratum in
-
ERRATUM.Rev Assoc Med Bras (1992). 2023 May 8;69(4):eERRATA14. doi: 10.1590/1806-9282.2023D693ERRATUM. Rev Assoc Med Bras (1992). 2023. PMID: 37162120 Free PMC article.
Conflict of interest statement
Conflicts of interest: the authors declare there is no conflicts of interest.
References
-
- Ministry of Health Resolution of the Collegiate Board - RDC No. Ministry of Health (MS) National Health Surveillance Agency (ANVISA) 2015 Jan 03;26 Available from: https://bvsms.saude.gov.br/bvs/saudelegis/anvisa/2015/rdc0003_26_01_2015... .
-
- National Health Surveillance Agency Technical Note Technical Note No. 01/2017/GMESP/GGMED/ANVISA – 01/09/2017. National Health Surveillance Agency (ANVISA) Available from: https://static.poder360.com.br/2017/01/mevatyl.pdf .
-
- Brazilian Society of Pediatrics . Orientation Manual. Scientific Departments of Neurology and Pediatrics of Development and Behavior (2022-2024 term) Vol. 32. Brazilian Society of Pediatrics; Dec 13, 2022. Indications for cannabis use in pediatric patients with neurodevelopmental disorders and/or epilepsy: an evidence-based review. Available from: https://www.sbp.com.br/imprensa/detalhe/nid/indicacoes-para-o-uso-da-can...
MeSH terms
Substances
LinkOut - more resources
Full Text Sources